Share this publication:
Cardio-vascular diseases (CVD) contribute substantially to morbidity and mortality among individuals with type 2 diabetes (T2DM). Dyslipidemia and hypertension are the major modifible risk factors for this increased predilection. Lifestyle modifications and pharmacological interventions targeted at reducing blood pressure and altering adverse lipid profie have shown to reduce cardiovascular morbidity and mortality among individuals with T2DM.
About the publisher:
iMedPub Limited is a publishing house registered in UK, publishing medical books and journals since 2005. As an open service to doctors and biomedical researchers, it is driven by clinicians and researchers for themselves, while serving the interests of the general public. iMedPub disseminates research in a tiered system, beginning with our specialty books and journals and then working upwards. The grand vision of iMedPub is a world where all medical researchers and health professionals have an equal opportunity to seek, share and create knowledge. As we are a low cost academic publisher we offer the lowest article processing charges of all biomedical journals and publish books free of charges for authors.